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Abstract: The majority of the genome in animals and
plants is transcribed in a developmentally regulated
manner to produce large numbers of non–protein-coding
RNAs (ncRNAs), whose incidence increases with develop-
mental complexity. There is growing evidence that these
transcripts are functional, particularly in the regulation of
epigenetic processes, leading to the suggestion that they
compose a hitherto hidden layer of genomic program-
ming in humans and other complex organisms. However,
to date, very few have been identified in genetic screens.
Here I show that this is explicable by an historic emphasis,
both phenotypically and technically, on mutations in
protein-coding sequences, and by presumptions about
the nature of regulatory mutations. Most variations in
regulatory sequences produce relatively subtle phenotyp-
ic changes, in contrast to mutations in protein-coding
sequences that frequently cause catastrophic component
failure. Until recently, most mapping projects have
focused on protein-coding sequences, and the limited
number of identified regulatory mutations have been
interpreted as affecting conventional cis-acting promoter
and enhancer elements, although these regions are often
themselves transcribed. Moreover, ncRNA-directed regu-
latory circuits underpin most, if not all, complex genetic
phenomena in eukaryotes, including RNA interference-
related processes such as transcriptional and post-
transcriptional gene silencing, position effect variegation,
hybrid dysgenesis, chromosome dosage compensation,
parental imprinting and allelic exclusion, paramutation,
and possibly transvection and transinduction. The next
frontier is the identification and functional characteriza-
tion of the myriad sequence variations that influence
quantitative traits, disease susceptibility, and other
complex characteristics, which are being shown by
genome-wide association studies to lie mostly in non-
coding, presumably regulatory, regions. There is every
possibility that many of these variations will alter the
interactions between regulatory RNAs and their targets, a
prospect that should be borne in mind in future
functional analyses.
Introduction
Genome sequencing projects have shown that the numbers of
protein-coding genes and the extent of protein-coding sequences
do not change appreciably across the vertebrates nor indeed across
the metazoa as a whole, despite large differences in developmental
complexity [1]. On the other hand, the extent of non–protein-
coding intronic and intergenic sequences in genomes does increase
with developmental complexity, suggesting that these sequences
may contain increasingly elaborate regulatory information [1].
In recent years it has also become evident that the vast majority of
the mammalian genome, and that of other complex organisms, is
transcribed, apparently in a developmentally regulated manner, to
produce large numbers of ncRNAs that are antisense, intergenic,
interleaved, or overlapping with protein-coding genes [2–5]. In
addition,thereareincreasing reports(Figure 1) of thefunctionalityof
individual ncRNAs in mammals (Table 1), other animals (see, e.g.,
[6–8]), plants (e.g., [9,10]), and fungi (e.g., [11]), particularly in
relation to developmental processes [12]. These include the
involvement of ncRNAs in the regulation of the expression of
homeotic genes [7,13], oncogenes [14], and metabolic genes [15], as
well as in the regulation of skeletal development [16], eye
development [17], epithelial-to-mesenchymal transition [18], and
subcellular structures [19–22], among many others (for reviews and
additional examples, see [4,12,23–25]).
There is also compelling genome-wide evidence that the large
numbers of identified but as yet unstudied intronic, intergenic, and
antisense ncRNAs have intrinsic indices of functionality (Table 2),
as indicated by the following: (i) the conservation of their
promoters, splice junctions, exons, predicted structures, genomic
position, and expression patterns [2,26–36]; (ii) their dynamic
expression and alternative splicing during differentiation
[13,31,32]; (iii) their altered expression or splicing patterns in
cancer and other diseases [37–49]; (iv) their association with
particular chromatin signatures that are indicative of actively
transcribed genes [31,32]; (v) their regulation by key morphogens
and transcription factors [31,32,49,50]; and (vi) their tissue- and
cell-specific expression patterns and subcellular localization
[16,17,19–22,49,51–56].
Indeed, a recent study of over 1,300 mouse ncRNAs showed
that almost half of them exhibit precise expression patterns in
different parts of the brain, including different subregions of the
hippocampus, olfactory bulb, neocortex, and cerebellum [52].
While many ncRNAs, like other regulatory sequences (see below),
appear to be evolving quickly, including those with well-validated
functions [26], most retain conserved patches within them [26,32],
and some may be under positive selection, especially in the brain
[57]. At least some of these RNAs, including intronic RNAs, are
precursors for small regulatory RNAs like microRNAs (miRNAs),
small interfering RNAs (siRNAs), piwi-interacting RNAs (piR-
NAs), and small nucleolar RNAs (snoRNAs) [58–68]. Many
miRNAs are highly conserved from nematodes to humans,
whereas others are primate-specific, and their full repertoire
remains to be determined [4,69,70].
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of protein-coding genes and that, notwithstanding lineage-specific
innovations and splice variants, the primary basis of phenotypic,
especially morphological, radiation and higher complexity has
been the variation and expansion of the regulatory architecture
that controls the deployment of these protein components and
their isoforms during differentiation and development [71]. This
regulatory architecture is generally more plastic than protein-
coding sequences that are highly constrained by relatively strict
structure-function relationships, which is reflected by the fact that
regulatory sequences evolve at widely different rates [72–75].
These sequences range from promoter regions that have no
recognizable sequence similarity yet direct orthologous patterns of
gene expression between fishes and mammals [76] to highly
conserved non-genic elements [77,78], and ‘‘ultraconserved’’
sequences that have remained essentially unchanged over
hundreds of millions of years of vertebrate evolution and appear
to act as tissue-specific enhancers that regulate gene expression
during development [79–82].
Regulatory sequences are also generally assumed to operate
through their interactions with sequence-specific transcription
factors and other regulatory proteins, but this assumption has been
made in ignorance, until recently, of the extent of developmentally
regulated transcription of ncRNAs from the genome, including
many regions spanning enhancers and promoters (see, e.g.,
[45,83–86]). The possibility is therefore that the genomes of
mammals and other complex organisms encode a large repertoire
of regulatory RNAs [4]. Indeed, the case has been made that a
much higher degree of regulatory sophistication, aided by the co-
option of the considerable powers of RNA to transmit sequence-
specific information, was a prerequisite for the evolution of
developmentally complex organisms [87,88], and that many of
these RNAs may be involved in the regulation of developmental
processes, including the epigenetic trajectories that underpin them,
for which there is increasing evidence [12,89].
However, if these ncRNAs are functional and important in
developmental and physiological processes, why have so few been
identified in genetic screens to date? Here I outline the emerging
evidence for ncRNA involvement in key molecular genetic
phenomena and in specific functions and phenotypes. I also
outline the expectational, perceptual, and practical factors that
may collectively account for the low genetic visibility of individual
ncRNAs. Awareness of these factors and the possibility that the
structure of the genomic programming of complex organisms is
different from our current understanding may lead to the
increased recognition of ncRNAs in genetic analyses, assisted by
the emerging fusion of genetics, genomics, and systems biology.
Phenotypic Impact
The ability to detect a relevant mutation or variation is
dependent on the sensitivity of the phenotypic screen. Mutations
in protein-coding sequences usually give severely compromised
(i.e., obvious) phenotypes, whereas those in regulatory sequences
often do not. Proteins are the key structural and functional
analogue components of cells, and the loss of their function is often
disastrous, leading in many cases to obvious defects, and in some
cases to embryonic lethality. Mutations in generic transcription
factors and other ‘‘regulatory’’ proteins are included, and their loss
causes pleiotropic effects on gene expression at many loci and
plays an important role in the molecular etiology of cancer
[71,90,91]. This is in contrast to regulatory sequences, which,
when damaged, may only affect a small part of the network, with
more restricted and subtle consequences, often referred to as
quantitative trait variations. Indeed the use of the word
‘‘mutation’’, as opposed to ‘‘variation’’, reflects an inherent bias
in the identification of genetic factors that influence phenotype in
animals, with those exhibiting strong effects understandably
having taken precedence over those that do not, both perceptually
and practically. Consistent with this, until recently, there were
Figure 1. The recent rise in papers on ncRNAs. The number of indexed Medline entries with the words ‘‘non-coding RNA’’, ‘‘noncoding RNA’’,
‘‘non-protein-coding RNA’’ or ‘‘ncRNA’’ in the title, abstract or keywords is plotted per year. Data courtesy of Ryan J. Taft.
doi:10.1371/journal.pgen.1000459.g001
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Name Characteristics Function
Experimental
Methodology
a References
Air 108 kb; transcribed from an antisense
promoter located in intron 2 of Igf2r
Regulates genomic imprinting of a cluster of
autosomal genes on mouse chromosome 17
Mutagenesis; FISH; ChIP;
RNA-IP
[156,189,196]
BACE1AS ,2 kb; transcribed antisense to beta-
secretase-1 (BACE1) gene, elevated in
Alzheimer disease
Regulates BACE1 expression in vitro and in
vivo, influences amyloid-beta 1–42 levels
shRNA and siRNA knockdown [197]
BC1 152 nt; expressed by a specific subset
of neurons in the central and peripheral
nervous system; dendritic location
Affects exploratory behaviour and anxiety,
represses translation by targeting initiation
factor 4A helicase
In vivo knockout, biochemical
analyses
[100,198]
Borg ,2.8 kb; induced by bone morphogenic
proteins (BMPs) and osteogenic proteins
Regulates BMP-induced differentiation of
C2C12 cells into osteoblastic cells
Antisense knockdown [199]
CCND1
associated
ncRNAs
Unspecified sizes; transcribed from the
promoter region of the cyclin D (CCND1)
gene; induced by DNA damage signals
Allosterically modifies the RNA-binding
protein TLS (‘‘translocated in liposarcoma’’),
leading to inhibition of CREB-binding protein
and histone acetyltransferase activities to
repress cyclin D1
ChIP; RNA-IP; siRNA
knockdown
[200]
CUDR ,2.2 kb; up-regulated in a doxorubicin-
resistant human squamous carcinoma
Regulates drug sensitivity, cellular
transformation and apoptosis
Overexpression [201]
EGO ,1.0 and 1.7 kb; highly expressed in
human bone marrow and in eosinophil
development
Regulates expression of myelin basic protein
and eosinophil-derived neurotoxin mRNAs
siRNA knockdown [202]
DHFR upstream Unspecified size; transcribed upstream of
the dihydrofolate reductase (DHFR) gene
Regulates DHFR expression by formation of
triple helix in the DHFR promoter
siRNA knockdown,; ChIP;
RNA-IP, other
[15]
Evf-2 ,3.8 kb; antisense to Dlx6; developmentally
regulated, expressed in the ventral forebrain
Cooperates with Dlx-2 in vivo to increase the
transcriptional activity of the Dlx-5/6
enhancer in a target and homeodomain-
specific manner
Overexpression; siRNA
knockdown; mutagenesis;
ChIP
[154]
Gadd7 754 nt; induced by lipotoxic-stress Regulates lipid-induced oxidative and ER
stress
Mutagenesis; shRNA
knockdown
[203]
GAS5 ,7 kb; growth arrest-specific transcript,
multiple splice isoforms, encodes several
snoRNAs in its introns, down-regulated in
breast cancer
Controls apoptosis and the cell cycle in
lymphocytes
siRNA knockdown;
overexpression
[204]
H19 2.3 kb; imprinted (maternal allele active) at
the Igf2 locus; strongly expressed during
embryogenesis; up-regulated in various
tumours
Complex functions, influences growth by
way of a cis control on Igf2 expression
implicated as both a tumour suppressor
and an oncogene
siRNA knockdown;
overexpression; in vivo
knockout
[205–207]
HOTAIR 2.2 kb; transcribed from the HOXC locus
from a position intergenic and antisense
to the flanking HOXC11 and HOXC12 genes
Epigenetically silences gene expression at
the HOXD locus
siRNA knockdown [13]
HOTAIRM1 483 nt; specific to the myeloid lineage Involved in RA-induced expression of HOXA1
and HOXA4 during myeloid differentiation,
and induction of myeloid differentiation
genes CD11b and CD18
shRNA knockdown [49]
Hsr1 ,600 nt; ubiquitously expressed Required for heat shock response siRNA and antisense
knockdown
[208]
IGS RNAs 150–300 nt; originate from the intergenic
spacers (IGS) that separates rRNA genes;
bind to the chromatin remodelling complex
NoRC
Required for the nucleolar localization of
NoRC and epigenetic control of the rDNA
locus
Mutagenesis; antisense
knockdown
[209]
Kcnq1ot1 91 kb; paternally expressed from Kcnq1
imprinting control region
Mediates organization of a lineage-specific
nuclear domain involved in epigenetic
silencing of the Kcnq1 imprinting control
region
Mutagenesis; ChIP; RNA/DNA
FISH
[22,155,
157,210]
Khps1a 1,290 nt; originates from the CpG island
and overlaps a tissue-dependent
differentially methylated region of Sphk1
Regulates DNA methylation in the tissue-
dependent differentially methylated region
of Sphk1
Overexpression [211]
lincENC1 Size unspecified; ,181 kb from Enc1 Regulates cell proliferation in embryonal
stem cells
shRNA knockdown [32]
MEG3 ,1.6 kb; maternally expressed from the
Dlk1-Gtl2 imprinted locus
Regulates p53 expression, inhibits cell
proliferation in the absence of p53
Overexpression, mutagenesis [192]
PLoS Genetics | www.plosgenetics.org 3 April 2009 | Volume 5 | Issue 4 | e1000459relatively few regulatory mutations identified among the catalogue
of known human mutations that are associated with overt genetic
disease.
There is, of course, a wide spectrum of effects of both coding
and noncoding mutations (Figure 2), and there are exceptions to
the rule in both directions. Loss-of-function mutations in some
protein-coding genes have mild effects [92], as exemplified by as
knockouts of the mammalian genes encoding calbindin D9k [93]
and C/EBPdelta [94,95], and the significant number of yeast
genes that show no observable phenotype. Reciprocally, knockouts
of some highly conserved miRNAs, many of which have multiple
targets, give strong phenotypes [96–98], even though very few
Name Characteristics Function
Experimental
Methodology
a References
MEN e/b
(Neat1)
,3.5 and ,23 kb; up-regulated upon
muscle differentiation; transcribed from the
multiple endocrine neoplasia 1 (MEN1) locus
Required for the structural integrity of
nuclear paraspeckles
Antisense, siRNA knockdown;
overexpression; FISH
[19–21]
ncR-uPAR ,350 bp; upstream of human protease-
activated receptor-1 (PAR-1) gene
Up-regulates Par-1 promoter Overexpression [212]
Nkx2.2AS 4.3 kb; antisense to Nkx2, preferentially
expressed in the nervous system
Enhances oligodendrocytic differentiation Overexpression [213]
NRON ,2.7 kb; enriched in placenta, muscle, and
lymphoid tissues
Modulates NFAT nuclear trafficking siRNA knockdown [214]
p15AS 38.4 kb; antisense to the tumour suppressor
gene p15
Epigenetically silences p15 expression Overexpression [14]
PCGEM1 1,643 nt; prostate tissue-specific and prostate
cancer-associated
Inhibits apoptosis induced by doxorubicin Overexpression [215]
PRINS ,3.6 kb; elevated expression in psoriatic
epidermis; regulated by the proliferation
and differentiation state of keratinocytes.
Required for cell viability after serum
starvation
siRNA knockdown [42]
PINC ,1 and 1.6 kb; developmentally regulated,
expressed in mammary gland
Performs dual roles in cell survival and
regulation of cell-cycle progression
siRNA knockdown; FISH [216]
RepA ,1.6 kb; internal to Xist Recruits the Polycomb complex, PRC2, to the
inactive X chromosome, with Ezh2 serving
as the RNA binding subunit
ChIP; FISH; overexpression;
shRNA knockdown
[128]
SAF 1.5 kb; transcribed from the opposite strand
of intron 1 of the human Fas gene
Regulates Fas-mediated but not TNF-alpha-
mediated apoptosis
Overexpression [217]
SatIII Various sizes up to .1.4 kb; transcribed from
satellite DNA associated with, and localized in,
nuclear stress bodies
Mediates recruitment of RNA processing
factors to, and formation of, nuclear stress
bodies
Antisense and siRNA
knockdown
[218]
SCA8 Predicted gene product underpinning the
triplet repeat expansion-induced
neurodegenerative disease Spinocerebellar
Ataxia 8
Induces late-onset, progressive
neurodegeneration in the Drosophila retina;
associates with the RNA binding protein
staufen
Ectopic expression in
Drosophila; genetic
modifier screen
[39]
TERRA /
TelRNAs
Various sizes; transcribed from and associated
with telomeres; contain UUAGGG repeats
May form G-quartet structures with telomere
DNA; inhibit telomerase activity
RNA FISH; oligo-nucleotide
inhibition
[219,220]
Tsix ,40 kb; antisense to Xist Epigenetically silences Xist expression by
inhibiting RepA recruitment of polycomb
complexes to maintain the active X
chromosome in females
Mutagenesis [128,221–223]
TUG1 6.7 kb; expressed in the developing retina and
brain
Required for the proper formation of
photoreceptors in the developing rodent
retina
shRNA knockdown [17]
UCA1 1,442 nt; expressed in embryonic development
and bladder cancer
Enhances tumorigenic behaviour of bladder
cancer cells in vitro and in vivo
Overexpression [224]
Xist ,17 kb; mosaic expression in females Epigenetically controls dosage compensation
by silencing one of the two X chromosomes
Mutagenesis for recent
review see [99]
Y RNAs 83–112 nt; up-regulated in cancer; bound by
Ro autoantigen
Regulate cell DNA replication and cell
proliferation
siRNA knockdown [47,225]
Zeb2NAT .680 nt; antisense to Zeb2, a transcriptional
repressor of E-cadherin
Regulates splicing of the Zeb2 59 UTR Overexpression [226]
Zfh-5AS ,10 kb; expressed in particular regions of
the developing brain
Regulates expression of the transcription
factor Zfh-5 mRNA
Mutagenesis [227]
This list is not exhaustive, and there are other examples of functional ncRNAs in mammals (see e.g. [228]) as well as of regulatory and structural ncRNAs in other animals,
plants, fungi (see e.g. [6–11]) and bacteria [229].
aAbbreviations used are: siRNA, short interfering RNA; shRNA, short hairpin RNA; FISH, fluorescence in situ hybridization; ChIP, chromatin immunoprecipitation; RNA-IP,
immunoprecipitation of RNA associated with particular proteins.
doi:10.1371/journal.pgen.1000459.t001
Table 1. cont.
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elegans and Drosophila, and none have been identified in mice,
despite the intensity of such screens (see below). Moreover, to date,
no naturally arising mutations have been discovered in the Xist
gene in either humans or mice, despite the central role that this
ncRNA plays in embryogenesis and in X-chromosome dosage
control in females [99], possibly because such mutations are lethal.
On the other hand, the potential subtlety of mutations in
ncRNAs, even when they are targeted by reverse genetics, is
illustrated by the case of BC1, which is expressed in synaptoden-
dritic domains of neurons in rodents. Knockout of this transcript
produces no obvious physical or neurological abnormality, and the
mutant mice were initially indistinguishable from wild type, but
were subsequently found to have reduced exploratory behaviour
and consequently a higher mortality in field experiments [100].
Thus this ncRNA causes a subtle behavioural phenotype that is
invisible in the cage, and would escape detection in superficial
forward genetic screens, but is almost certainly strongly disadvan-
tageous in the wild. Similarly, deletions or insertions in some
ultraconserved enhancers yield no discernable abnormality
[101,102], despite the fact that these sequences are clearly under
intense selection [103], suggesting insensitivity of phenotypic
screens in captivity or redundancy in the regulatory architecture
(perhaps associated with developmental robustness) that we have
yet to understand.
Monogenic Diseases and High Penetrance
Mutations
The generally stronger effects of protein-coding mutations leads
to a sampling bias, in that more severe phenotypes are not only
more easily discerned but have also been more likely to attract
further study, both in medical contexts and in model organisms. In
medicine, mutations involving catastrophic component damage
have been traditionally referred to as ‘‘monogenic diseases’’ and
were the primary targets of study in the pioneering days of human
genomics, just a decade or two ago, when the protein-coding genes
underpinning cystic fibrosis, Huntington disease, and Duchenne
muscular dystrophy, among others, were identified by positional
mapping and cloning approaches. Thus, in humans, mutation
mapping is still both a young science and extraordinarily difficult
due to the sheer complexity of the genome, which naturally led to
an initial focus on severe loss-of-function diseases that exhibit
simple inheritance patterns with high penetrance (‘‘single gene–
large effect’’) making them amenable to identification. This is now
changing with the increasing availability of human genome
sequences, and the application of genome-wide association
(GWA) studies to the mapping of the genetic components of
Table 2. Indices of the functionality of ncRNAs.
Feature References
Conservation of promoters [2,27,32]
Conservation of splice junctions [27]
Conservation of sequence [26,27,32]
Conservation of genomic position [31,33,34]
Conservation of secondary structure [28–30]
Positive selection [230]
Conservation of expression [35,36]
Dynamic expression and alternative splicing [13,31,32]
Altered expression or splicing in cancer and other
diseases
[37–49]
Association with particular chromatin signatures [31,32]
Regulation by morphogens and transcription factors [31,32,49,50]
Tissue- and cell-specific expression patterns [16,17,19–22,49,51–56]
Specific subcellular localization [19–22,52,56]
doi:10.1371/journal.pgen.1000459.t002
Figure 2. The contrasting effects of mutations in protein-coding and regulatory sequences. A conceptual diagram of the spectrum of
phenotypic effects of mutations in sequences encoding proteins and other analogue components of cells (continuous line) versus variations in non-
coding sequences that specify regulatory interactions (dashed line).
doi:10.1371/journal.pgen.1000459.g002
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the majority of the interesting phenotypic differences between
individuals and species.
Complex Traits and GWA Studies
Indeed, functional classification of sequence variations that have
been identified by GWA studies to be associated with complex
traits, albeit still strongly focused on those of medical importance,
shows that the vast majority of variations are located in noncoding
regions [104,105]. In most cases, the causative mutations have yet
to be defined, and their mechanistic basis is unknown—especially
whether they affect cis-acting binding sites for regulatory proteins
or the function or expression of regulatory RNAs. One good
candidate for the latter is the ncRNA ANRIL, which lies antisense
to CDKN2A and traverses a noncoding region centromeric to
CDKN2A, a region implicated in a range of complex diseases
including cancer, type 2 diabetes, periodontitis, and coronary
heart disease [106–112]. Perplexingly, however, those variants
mapped by GWA studies to date account for only a small
proportion of genetic variation in disease or quantitative traits
[113]. These traits are clearly multifactorial and may be affected
by rare variants with strong effects that have yet to be recognized.
The identification of the sequence changes that directly
underpin quantitative trait variations has thus far been possible,
or at least achieved, only in well-structured pedigrees in plants and
animals. In the few cases where such quantitative trait loci (QTLs)
have been mapped to completion, most have been found to be
located in noncoding sequences, specifically: (i) regulatory
sequences in promoters and distal enhancers (e.g., the ‘‘teosinte
branched1’’ mutation affecting branching and inflorescence in
maize [114]); (ii) 39 untranslated regions (UTRs) (e.g., those
underlying Tourette’s syndrome [115], and muscular hypertrophy
in sheep [116]; see also below); (iii) introns (e.g., a QTL affecting
muscle growth in domestic pigs [117]); or (iv) intergenic sequences
of unknown transcriptional status (e.g., the ‘‘callipyge’’ mutation
causing posterior muscular hypertrophy in sheep [118]). The latter
occurs in an imprinted locus and affects the expression of a
number of protein-coding and ncRNA genes [119] associated with
an unusual genetic phenomena termed ‘‘polar overdominance’’
[120], which may also occur in humans [121]. While these
mutations are reasonably assumed to be regulatory in nature, their
mechanistic basis has not been determined, although in the latter
case, there is some evidence for the involvement of trans-acting
miRNAs [119,122]. In addition, linkage studies in a large family
have recently identified the ncRNA AK023948 as a candidate
susceptibility gene for papillary thyroid carcinoma [123].
Type of Mutation and Sensitivity of the Model
System
The nature of the organism under study and the type of
mutations also affect the outcome of genetic screens—relevant
single-base mutations are not only harder to identify than
insertions/deletions, especially in mammalian genomes and even
in inbred mice, but also have milder effects on regulatory
sequences.
Most mutations induced by ENU mutagenesis involve single-
base changes, which are also, along with small indels and copy
number variations, the most common type of natural variation in
humans and other mammals, where few regulatory mutations
have yet been identified. Whereas a nonsynonymous mutation in a
protein-coding sequence can have severe effects on the structure
and function of the protein, many regulatory sequences have loose
consensus sequences, and variations in them, as noted already,
may have subtle effects and go unnoticed, especially in superficial
phenotypic screens.
On the other hand, insertions and deletions dominate
mutational screens in Drosophila, and a large number map to
noncoding intergenic and intronic regions. This is exemplified by
the intensively studied bithorax complex, where there are not only
mutations known in the coding sequences for the homeotic protein
Ultrabithorax (Ubx), but also in upstream (bithoraxoid or bxd) and
intronic (Contrabithorax or Cbx and anterobithorax or abx) sequences
[124], which contain conserved blocks within them [125–127].
Such noncoding mutations are interpreted as affecting orthodox
cis-acting enhancer sequences (i.e., those that bind cis-acting
regulatory proteins), despite the fact that (for example) bxd
mutations fall within a region that is transcribed during early
embryogenesis into a complex set of short polyadenylated RNAs
with no coding potential. These RNAs arise by alternative splicing
of at least 11 exons derived from a 26-kb primary transcript [126].
Moreover, these regulatory regions involve interaction with
Polycomb-group and Trithorax-group proteins, which are in-
creasingly implicated as being directed to their sites of action by
ncRNAs [7,13,128] (see below).
Similarly the iab regulatory elements of the bithorax complex
that control the expression of abdominal-A and Abdominal-B, and
consequently the identities of the 2nd–9th abdominal segments,
are transcribed into ncRNAs in a spatially ordered pattern [129].
It has also recently been shown that 231 ncRNAs are expressed
from the four human HOX loci in a spatially and temporally
ordered progression along developmental axes, one of which
(termed HOTAIR) from the HOXC locus controls expression of the
HOXD locus in trans, as shown by siRNA-mediated knockdown
experiments [13]. None of these ncRNAs has yet been specifically
associated with a genetic variant in mammals, although in
Drosophila there are many homeotic mutations that lie in regions
encompassed by ncRNAs [12,124], and Drosophila geneticists were
clearly intrigued by them [130]. Moreover, as pointed out by Rinn
et al. [13], the existence of such transacting regulatory ncRNAs
may explain the observation that the deletion of the entire HOXC
locus exhibits a milder phenotype than the deletion of individual
HOXC genes [131].
Despite the now known importance of miRNAs in the control of
gene expression [67,132], only four miRNA loci have been
identified in intense genetic screens in C. elegans and Drosophila, and
none in mammals. This may be partly due to the fact that C. elegans
is hermaphroditic and naturally driven to homozygosity in
individual isolates, without the need for laborious back-crossing,
and flies are routinely bred to homozygosity in mutational screens,
making screening of recessive mutations far more efficient than in
mice. There was also an element of serendipity, in that the first
identified miRNA locus, lin-4, expressed a small RNA whose
complementary sequence was present in multiple copies in the 39
UTR of its target gene, lin-14, and thus was relatively easy to
pinpoint [133,134], which also applied in the subsequent case of
let-7 [135].
Following the discovery of miRNAs, Drosophila mutants of
uncertain provenance that mapped in gain-of-function screens to
noncoding regions were re-analysed, and one that regulates
growth [136], termed bantam, was identified to encode a miRNA
[137]. The miRNAs let-7 [135] and lsy-6 [138] were also identified
genetically in C. elegans, not in other organisms, despite the former
being not only highly conserved in sequence and expression
pattern throughout metazoan evolution [139], but also funda-
mental to normal and abnormal developmental processes [140–
142], as are many other miRNAs [143]. On the other hand, lsy-6
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in deep sequencing libraries. Subsequently most known miRNAs,
of which there are hundreds in mammals, and later piRNAs, have
been identified by biochemical not genetic means. In view of the
lsy-6 example and the clearly incomplete sampling of the small
RNA transcriptome, even using deep sequencing [70], there are
likely to be many more.
Expectations and Interpretations
There has also been a strong expectation that mutations that
have phenotypic effects will map to protein-coding genes or cis-
regulatory elements that interact with regulatory proteins. The
former has influenced the practical strategies for mutation
searching, in terms of a focus on exon scanning of candidate
genes (see below), and the latter has influenced the interpretation
of regulatory variations, although in only a few cases has the
mechanistic basis been determined [71,145]. Some mutations map
to gene ‘‘deserts’’ (see, e.g., [146]), and while it is conceivable that
they affect distal enhancers (see, e.g., [147]), it is interesting and
relevant to note that there is good evidence that enhancers and
other regulatory sequences are transcribed into ncRNAs in the
cells in which they are active [45,83–86], and hence may act in
part via ncRNAs.
Transvection and Locally Acting ncRNAs
Many loci, such as the bithorax complex referred to earlier,
exhibit a genetic phenomenon called ‘‘transvection,’’ whereby a
wild-type regulatory region upstream of a defective protein-coding
sequence on one chromosome can rescue a relatively normal
phenotype, when it is combined with a mutant regulatory region
linked to a wild-type protein-coding sequence on the homologous
chromosome (both of which give mutant phenotypes when
homozygous) [130]. This phenomenon is well documented in
Drosophila but appears to occur in most animals and has been
interpreted as a physical cross-talk between functional cis-acting
promoters or enhancers on one chromosome to engender
transcription of adjacent protein-coding genes on the other, since
the effect is usually pairing-dependent and lost when the
regulatory and protein-coding sequences are separated to
nonsyntenic positions in the genome [130,148]. However, this is
not always the case—at some loci, transvection between regulatory
elements and protein-coding sequences can operate over large
distances (even between different chromosomes) [149–152],
suggesting the involvement of a trans-acting signal. Moreover,
many promoter elements that exhibit transvection are transcribed
into ncRNAs, and transvection is altered in Polycomb and zeste
mutants [125–127,130], indicating that epigenetic processes
(which may be regulated by ncRNAs, see below) are involved.
Taken together, these observations raise the possibility that
transvection is mediated by trans-acting RNAs [153], in which
case the observed cross-complementation may occur simply as a
result of a compound heterozygosity between a regulatory ncRNA
locus and a nearby protein-coding locus whose expression is
controlled by it.
In support of this proposition, there is now rapidly emerging
evidence that many ncRNAs derived from either same or opposite
strands act locally to regulate the epigenetic status and expression
of nearby protein-coding genes, often involving the recruitment of
chromatin-activator or repressor complexes [7,13–16,89,154–
157], with sense-antisense pairs in some cases being the substrate
for the generation of siRNAs [63–65,68]. Moreover the many
deletion studies of gene promoter regions to define regulatory
sequences have almost always assumed, physically and mechanis-
tically, that resultant changes to expression patterns are due to the
loss of cis-acting protein binding sites rather than deletions in the
same or opposite strand ncRNAs that frequently traverse and are
expressed from the same region. The complexity of these
relationships is illustrated by the examples of the ncRNA DLeu2
(deleted in lymphocytic leukemia 2), which has multiple splice variants
and lies antisense to genes in a region deleted in various
malignancies [158], and the ncRNA ANRIL referred to earlier.
Thus the interpretation of the mechanisms by which such
mutations operate remains not only an open question but a
difficult problem to disentangle, given the complex interlacing and
overlapping coding and noncoding transcripts, and splice variants
thereof, that are expressed from many loci in different cells and
tissues [2,3].
Transinduction, Ectopic Expression and Gene Knockouts
RNA is also implicated in a curious genetic phenomenon called
‘‘transinduction,’’ whereby transient transfection of a b-globin
gene induces transcription of the ‘‘locus control region’’ and
intergenic regions at the chromosomal b-globin locus in non-
erythroid cell lines. This effect is dependent on transcription of the
globin gene from the transfected plasmid and its association with
the endogenous b-globin locus, but not on protein expression, and
therefore is RNA-mediated [83], although the responsible
sequences have not been mapped. Indeed, the general assumption
that mRNA is simply an intermediate between gene and protein,
albeit with cis-acting regulatory elements, may be incorrect, and
there may be a false dichotomy between coding and noncoding
RNA [159]. This is indicated by the complexity of overlapping
sense and antisense coding and noncoding transcripts from most
genomic loci [2–5] and evidence that protein-coding sequences are
under constraint not only at the amino acid sequence level, but
also within their RNA sequence [160]. Moreover, given that many
gene knockout studies concomitantly delete potential sources of
regulatory ncRNAs such as introns (given that many miRNAs and
all snoRNAs are sourced from introns) and antisense transcribed
sequences, all aspects of the observed phenotypes cannot be
unequivocally or solely ascribed to the loss of the protein without
complementation studies or more precise deletions that are rarely
done for reasons of technical difficulty.
Technical Limitations
The focus on protein-coding sequences has been reinforced by a
practical problem, especially in mammals. Mutation mapping
studies using whole-genome scanning techniques usually have not
pinpointed the causative mutation or variation, and the affected
region may encompass one megabase or more. Until recently,
comparative sequencing of such regions was not feasible, and in
any case it can be very difficult to sort the relevant polymorphism
from the considerable background variation in huge intergenic
and intronic regions, especially in outbred human populations. In
most circumstances, understandably, investigators have resorted to
analysing the most plausible candidate genes (recently including
those expressing noncoding transcripts or ESTs [158,161]) usually
involving scanning of known exons (and sometimes the immediate
59 flanking promoter sequences and UTRs) in the region by PCR
amplification, in the hope that they can identify the causative
mutation in these locations, which in turn are the ones that are
then reported in the literature. However, there are many informal
reports of mapping studies that have not identified such exonic
mutations, and which consequently lie in abeyance, including (as
noted already) the large number of GWA studies that have
mapped disease-associated variations to noncoding, presumably
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the relevant variations in these regions may be to focus on
sequences that exhibit evolutionary conservation and/or whose
expression is altered [162]. Conversely, reverse genetic screens
looking for phenotypes associated with ncRNAs might target
conserved blocks within them and focus on tissues where they are
known to be expressed.
Mutations Affecting trans-Acting Functions of
mRNAs
As noted above, regulatory mutations have been identified in
the 39 UTRs of mRNAs, such as those underlying Tourette’s
syndrome [115] and muscular hypertrophy in sheep [116], which
appear to involve gain- or loss-of-function of miRNA binding sites.
Interestingly, however, a number of other reported 39 UTR
mutations do not appear to act in cis to regulate the expression of
the associated mRNA, as is normally assumed, but rather in trans
as ncRNAs. For example the 39 UTR of prohibitin (in the absence
of the associated protein-coding sequences) can inhibit cell cycle
progression in one complementation group of breast cancer–
derived cells that is characterized by naturally occurring mutations
in the 39 UTR, indicating that these sequences are in fact
functioning, in part, as trans-acting ncRNAs [163,164]. Similarly,
the oogenesis defect observed in Drosophila oskar null mutants is
rescued by the oskar 39 UTR alone [165].
A trans-acting function for mRNA sequences, both coding and
noncoding, may be more general that expected. For example, the
introduction of cancer-associated silent point-mutations in p53
mRNA alters its binding to the protein Mdm2, which in turn alters
p53 expression and function [166]. The 39 UTRs of troponin I,
tropomyosin, and a-cardiac actin have been shown to reactivate
muscle-specific promoters in a differentiation-defective myoblast
mutant, enhance the differentiation of wild-type muscle cells, and
suppress the proliferation of fibroblasts independently of their
normally associated protein-coding sequences [167]. Similarly, the
39 UTRs of tropomysin [168] and ribonucleotide reductase [169]
can suppress tumour formation, and the 39 UTR of the DM
protein kinase gene, which is involved in myotonic dystrophy,
inhibits the differentiation of C2C12 myoblasts [170]. Moreover,
many 39 UTRs in mouse appear to be expressed separately from
their mRNAs in a developmentally regulated manner [171].
There other examples of mutations in sequences encoding 39
UTRs that do not act via the UTR. A single nucleotide
polymorphism that determines susceptibility to an autoimmune
thyroid disease occurs both within the 39 UTR of the ZFAT gene
(zinc-finger gene in AITD susceptibility region) and also within the
promoter of an antisense transcript (SAS-ZFAT), and increases the
expression of ZFAT not through increasing mRNA stability, but by
repressing the expression of the antisense transcript [172].
Regulation of Complex Genetic Processes by
ncRNAs
Apart from the general presumption that most ncRNAs will be
involved in regulation, variations in which will often have,
individually, subtle effects on phenotype, there is, in fact, general
evidence of their positive genetic signatures, as ncRNAs underpin
most, if not all, complex genetic processes in the higher organisms.
These include RNA interference-related phenomena such as co-
suppression and transcriptional gene silencing [132,173–176], as
well as position effect variegation [177,178], hybrid dysgenesis
[179], parental imprinting, X-chromosome dosage compensation
and allelic exclusion [180], germ cell reprogramming [181], and
paramutation [182,183], all of which involve epigenetic processes.
Indeed, as noted already, there is increasing evidence that a major
function of ncRNAs, both small and large, is the regulation of
epigenetic memory through modifications to DNA and chromatin
structure, involving the recruitment of DNA methyltransferases,
histone-modifying enzymes, and chromatin remodelling complex-
es to their appropriate sites of action (including ncRNA genes
themselves) in particular cells at particular stages of differentiation
(for reviews, see [12,89,184]; also Table 1).
Examples of Mutations in ncRNAs
There are some known examples of mutations in ncRNAs, aside
from those mentioned already, that give recognizable phenotypes
or that are strongly implicated in altered phenotypic states. These
include a triplet repeat expansion in the ncRNA SCA8, which
causes the human neurodegenerative disease Spinocerebellar
Ataxia 8 (which as a transgene can induce progressive retinal
neurodegeneration in Drosophila) [39] and other examples of
deleterious gain-of-function mutations in noncoding RNAs
associated with diseases such as myotonic dystrophy [185],
deletions encompassing ncRNA loci and alterations to ncRNA
splicing patterns in various cancers [47,106,158,161,186,187], and
a SNP variant in an ncRNA MIAT that confers risk of myocardial
infarction [188]. They also include many ncRNAs, including small
nucleolar RNAs, that appear to be important in the mechanism of
imprinting [189] and the molecular etiology of associated
pathologies such as Prader-Willi syndrome [190,191], some that
are implicated as tumour suppressors [168,192], or that are
located at chromosomal translocation breakpoints associated with
B-cell lymphoma [193] and schizophrenia [194]. It has also been
shown that the translocation and induced expression of an
antisense, long ncRNA can cause the epigenetic silencing of the
adjacent a-globin gene, resulting in a-thalassemia [195].
Conclusion
There is not (yet) a huge catalogue of mutations in ncRNAs that
have been shown to affect phenotype, compared to those in
protein-coding sequences. However, on the assumption that most
ncRNAs are regulatory and that most regulatory regions have yet
to be assigned genetic signatures, it is no surprise that this may be
the case. On the other hand, as screening for variations affecting
complex traits becomes more sophisticated, it is reasonable to
anticipate that many will map to, and affect the function of,
ncRNAs. Certainly this possibility should be borne in mind in the
interpretation of such variations and the consequent studies to
define their mechanism of action. The functional analysis of
ncRNAs is in its infancy, but in situ hybridization, genomic, and
structural characteristics, and the perturbation of their expression
by overexpression and siRNA-mediated knockdown are emerging
as major tools (Tables 1 and 2). There seems little doubt that there
is a hidden world of regulatory architecture underpinning the
development of complex organisms that we have yet to explore,
both genetically and functionally.
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